{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:27:13Z","timestamp":1784690833146,"version":"3.55.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T00:00:00Z","timestamp":1481846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0168215","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T18:42:05Z","timestamp":1482172925000},"page":"e0168215","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study"],"prefix":"10.1371","volume":"11","author":[{"given":"Lukas","family":"Kirzinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Boy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Marienhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Schuierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Neu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Stefan","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Str\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kleylein-Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Baierlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Bogdahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Schalke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,16]]},"reference":[{"key":"ref1","first-page":"447","article-title":"Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?","volume":"127","author":"N Willcox","year":"1987","journal-title":"Am J Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/08916930903555935","article-title":"Thymoma and paraneoplastic myasthenia gravis","volume":"43","author":"A Marx","year":"2010","journal-title":"Autoimmunity"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.humimm.2011.12.022","article-title":"High prevalence of infections and autoimmunity in patients with thymoma","volume":"73","author":"A Holbro","year":"2012","journal-title":"Hum Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.athoracsur.2003.10.001","article-title":"Thymic tumors","volume":"77","author":"FC Detterbeck","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"EA Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"ref6","first-page":"184","article-title":"World Health Organization Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"WD Travis","year":"2015"},{"key":"ref7","first-page":"196","article-title":"WHO Classification of Tumours Series","author":"H Muller-Hermelink","year":"2004"},{"key":"ref8","first-page":"5","article-title":"WHO International histological classification of tumours","author":"J Rosai","year":"1999"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"A Masaoka","year":"1981","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China","volume":"95","author":"G Chen","year":"2002","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka-Koga Stage Classification for Thymic Malignancies","volume":"6","author":"F Detterbeck","year":"2011","journal-title":"J Thorac Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/JTO.0b013e3182745f73","article-title":"Thymoma \u2012 a clinico-pathological long-term study with emphasis on histology and adjuvant radiotherapy dose","volume":"7","author":"T Harnath","year":"2012","journal-title":"J Thorac Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","article-title":"Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis","volume":"22","author":"P Str\u00f6bel","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","article-title":"Thymic carcinoma outcomes and prognosis: Results of an international analysis","volume":"149","author":"U Ahmad","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/JTO.0000000000000393","article-title":"The impact of thymoma histotype on prognosis in a worldwide database","volume":"10","author":"C-A Weis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thorsurg.2010.08.001","article-title":"Management of Stage I and II Thymoma","volume":"21","author":"FC Detterbeck","year":"2011","journal-title":"Thorac Surg Clin"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","article-title":"Thymic malignancies: from clinical management to targeted therapies","volume":"29","author":"RJ Kelly","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin Plus Doxorubicin Plus Cyclophosphamide in Metastatic or Recurrent Thymoma: Final Results of an Intergroup Trial","volume":"12","author":"BPJ Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","article-title":"Thymoma and thymic carcinomas","volume":"99","author":"M Scorsetti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2003.09.022","article-title":"Multimodal management of stages III-IVa malignant thymoma","volume":"44","author":"S Bretti","year":"2004","journal-title":"Lung cancer (Amsterdam, Netherlands)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00000421-200112000-00007","article-title":"Multimodal Treatment of Metastatic Thymic Carcinoma Including High-Dose Chemotherapy With Autologous Stem Cell Transplantation Survival","volume":"24","author":"DB Geffen","year":"2001","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtcvs.2013.08.061","article-title":"Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial","volume":"147","author":"RJ Korst","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/JTO.0b013e3181f209a8","article-title":"Thymoma and thymic carcinoma: molecular pathology and targeted therapy","volume":"5","author":"P Str\u00f6bel","year":"2010","journal-title":"J Thorac Oncol"},{"key":"ref24","first-page":"245","article-title":"Somatostatin analogs for diagnosis and treatment of cancer","volume":"60","author":"G Weckbecker","year":"1993","journal-title":"PharmacolTher"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nrd1255","article-title":"Opportunities in somatostatin research: biological, chemical and therapeutic aspects","volume":"2","author":"G Weckbecker","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"ME Caplin","year":"2014","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group","volume":"27","author":"A Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1005774713202","article-title":"Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action","volume":"15","author":"E Woltering","year":"1997","journal-title":"Invest New Drugs"},{"key":"ref29","first-page":"3455","article-title":"Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization","volume":"54","author":"J Reubi","year":"1994","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4049\/jimmunol.143.3.1015","article-title":"Somatostatin gene expression in the thymus gland","volume":"143","author":"PJ Fuller","year":"1989","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0344-0338(99)80008-9","article-title":"Somatostatin receptor scintigraphy in thymoma imaging method and clinical application","volume":"195","author":"J Marienhagen","year":"1999","journal-title":"Pathol Res Pract"},{"key":"ref32","first-page":"634","article-title":"In Vivo Detection of Malignant Thymic Masses by Indium-111-DTPA-D-Phe1-octreotide scintigraphy","volume":"39","author":"S Lastoria","year":"1998","journal-title":"J Nucl Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00003072-199901000-00006","article-title":"Somatostatin Receptor Scintigraphy and Somatostatin Therapy in the Evaluation and Treatment of Malignant Thymoma","volume":"24","author":"K Lin","year":"1999","journal-title":"Clin Nucl Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199701233360405","article-title":"Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone","volume":"336","author":"G Palmieri","year":"1997","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/cncr.10374","article-title":"Somatostatin analogs and prednisone in advanced refractory thymic tumors","volume":"94","author":"G Palmieri","year":"2002","journal-title":"Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial","volume":"22","author":"PJ Loehrer","year":"2004","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"MM Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":"Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity","volume":"33","author":"UA Besinger","year":"1983","journal-title":"Neurology"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2307\/2530297","article-title":"One-sample multiple testing procedure for phase II clinical trials","volume":"38","author":"TR Fleming","year":"1982","journal-title":"Biometrics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e36411","DOI":"10.1371\/journal.pone.0036411","article-title":"Meta-analysis on the effects of octreotide on tumor mass in acromegaly","volume":"7","author":"A Giustina","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/1097-0142(19860315)57:6<1101::AID-CNCR2820570606>3.0.CO;2-A","article-title":"Chemotherapy of malignant thymoma. Case report and review of the literature","volume":"57","author":"E Hu","year":"1986","journal-title":"Cancer"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1210\/jcem-12-6-690","article-title":"Effect of ACTH on thymic masses","volume":"12","author":"LJ Soffer","year":"1952","journal-title":"J Clin Endocrinol Metab"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ejcts.2007.02.032","article-title":"Complete regression of a thymoma to glucocorticoids, commenced for palliation of symptoms","volume":"31","author":"S Barratt","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/cncr.21875","article-title":"Preoperative steroid pulse therapy for invasive thymoma: clinical experience and mechanism of action","volume":"106","author":"Y Kobayashi","year":"2006","journal-title":"Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0008-8749(86)90011-0","article-title":"Presence of glucocorticoid receptors in cultured thymic epithelial cells","volume":"100","author":"M Dardenne","year":"1986","journal-title":"Cell Immunol"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"EA Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/JTO.0000000000000296","article-title":"International Thymic Malignancy Interest G. A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria","volume":"9","author":"MF Benveniste","year":"2014","journal-title":"J Thorac Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0168215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T10:35:24Z","timestamp":1692614124000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0168215"}},"subtitle":[],"editor":[{"given":"Eric","family":"Deutsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,16]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0168215","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,16]]}}}